Public Employees Retirement System of Ohio acquired a new stake in Envista Holdings Corporation (NYSE:NVST – Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 50,107 shares of the company’s stock, valued at approximately $1,320,000.
A number of other hedge funds have also recently added to or reduced their stakes in the stock. GSA Capital Partners LLP acquired a new stake in shares of Envista during the 2nd quarter valued at $2,039,000. Pzena Investment Management LLC acquired a new position in Envista in the 2nd quarter worth about $30,494,000. SummitTX Capital L.P. bought a new position in Envista in the first quarter valued at about $4,268,000. Dimensional Fund Advisors LP raised its position in Envista by 1.6% in the first quarter. Dimensional Fund Advisors LP now owns 9,780,948 shares of the company’s stock valued at $248,130,000 after purchasing an additional 152,488 shares during the last quarter. Finally, Intech Investment Management LLC acquired a new stake in shares of Envista during the fourth quarter valued at about $2,501,000.
Analyst Upgrades and Downgrades
NVST has been the subject of a number of research reports. Deutsche Bank Aktiengesellschaft set a $32.00 price objective on shares of Envista in a report on Thursday, September 3rd. Robert W. Baird set a $34.00 price target on shares of Envista in a report on Thursday, August 6th. Wall Street Zen downgraded Envista from a “strong-buy” rating to a “buy” rating in a report on Saturday. Morgan Stanley set a $23.00 target price on Envista in a report on Thursday, August 6th. Finally, Mizuho set a $29.00 price target on Envista in a research note on Thursday, August 6th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and eight have assigned a Hold rating to the stock. According to data from MarketBeat, Envista presently has a consensus rating of “Moderate Buy” and an average target price of $29.71.
Envista Stock Performance
Shares of NVST opened at $26.81 on Wednesday. The company has a current ratio of 2.43, a quick ratio of 2.07 and a debt-to-equity ratio of 0.47. The firm’s fifty day simple moving average is $27.24 and its two-hundred day simple moving average is $26.26. Envista Holdings Corporation has a 12 month low of $18.77 and a 12 month high of $30.42. The stock has a market capitalization of $4.31 billion, a P/E ratio of 46.22, a price-to-earnings-growth ratio of 1.30 and a beta of 0.86.
Envista (NYSE:NVST – Get Free Report) last posted its quarterly earnings data on Wednesday, August 5th. The company reported $0.41 earnings per share for the quarter, topping the consensus estimate of $0.34 by $0.07. Envista had a return on equity of 7.88% and a net margin of 3.33%.The firm had revenue of $730.50 million during the quarter, compared to analyst estimates of $716.11 million. During the same period last year, the company posted $0.26 EPS. The business’s quarterly revenue was up 7.1% on a year-over-year basis. Envista has set its FY 2026 guidance at 1.500-1.550 EPS. As a group, analysts predict that Envista Holdings Corporation will post 1.53 EPS for the current year.
Insiders Place Their Bets
In other Envista news, SVP Mischa Reis sold 8,000 shares of the business’s stock in a transaction that occurred on Thursday, August 20th. The stock was sold at an average price of $27.50, for a total value of $220,000.00. Following the transaction, the senior vice president directly owned 27,321 shares of the company’s stock, valued at approximately $751,327.50. The trade was a 22.65% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.99% of the company’s stock.
About Envista
Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.
Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.
Featured Articles
- Five stocks we like better than Envista
- Tesla’s Robotaxi Launch Wasn’t the Moment Investors Expected
- Despite Post-Earnings Drop, Wall Street Analysts Eye New Highs for Broadcom Stock
- Morgan Stanley Eyes Good Things Ahead for Meta After $18 Billion Legal Settlement
- Q3 Earnings Could Be the Catalyst the Market Has Been Waiting For
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.
